Citation: | GAO Zi-xuan, WANG Xue-qing, ZHOU Gui-sheng, WANG Tian-shu, YU Bin, YAN Hui. Research Progress on Processing Methods, Chemical Constituents, Pharmacological Action, and Prediction Analysis of Quality Markers of Black Ginger[J]. Journal of Nanjing University of traditional Chinese Medicine, 2023, 39(9): 927-942. doi: 10.14148/j.issn.1672-0482.2023.0927 |
[1] |
神农本草经[M]. 3版. 北京: 学苑出版社, 2007: 139.
Shen Nong's Classic of the Materia Medica[M]. 3nd ed. Beijing: Academy press, 2007: 139.
|
[2] |
陶弘景. 名医别录: 辑校本[M]. 北京: 中国中医药出版社, 2013.
TAO HJ. Miscellaneous Records of Famous Physicians: Compilation of proof books[M]. Beijing: China press of traditional Chinese medicine, 2013.
|
[3] |
国家药典委员会. 中华人民共和国药典: 一部[M]. 北京: 中国医药科技出版社, 2020: 15.
National Pharmacopoeia Committee. People's Republic of China Pharmacopoeia: Ⅰ[M]. Beijing: China medical science and technology press, 2020: 15.
|
[4] |
苏敬. 新修本草: 辑复本[M]. 合肥: 安徽科学技术出版社, 1981: 166.
SU J. Newly Revised Materia Medica: Compilation copy[M]. Hefei: Anhui science & technology publishing house, 1981: 166.
|
[5] |
赵学敏. 本草纲目拾遗[M]. 2版. 北京: 中国中医药出版社, 2007: 324.
ZHAO XM. Supplement to The Grand Compendium of Materia Medica[M]. 2nd ed. Beijing: China press of traditional Chinese medicine, 2007: 324.
|
[6] |
吴仪洛. 本草从新[M]. 北京: 人民卫生出版社, 1990: 178.
WU YL. Thoroughly Revised Materia Medica[M]. Beijing: People's medical publishing house, 1990: 178.
|
[7] |
苏颂. 本草图经[M]. 合肥: 安徽科学技术出版社, 1994.
SU S. Herbal Illustrations[M]. Hefei: Anhui science & technology publishing house, 1994.
|
[8] |
四川省药品监督管理局. 四川省中药标准[S]. 成都: 四川科学技术出版社, 2021.
Sichuan Provincial Product Collection Administration Bureau. Sichuan Provincial Product Collection Associate[S]. Chengdu: Sichuan science & technology publishing house, 2021.
|
[9] |
DOUI-OTA M, MIKAGE M. Chemical study of ancient-type kankyo: The ginger fermented after soaked in water[J]. Tradit Med, 2013, 30: 158-163.
|
[10] |
汪晓辉, 周元雳, 卫莹芳, 等. 犍为干姜适宜加工方法的研究[J]. 时珍国医国药, 2007, 18(10): 2416-2418. https://www.cnki.com.cn/Article/CJFDTOTAL-SZGY200710047.htm
WANG XH, ZHOU YL, WEI YF, et al. Effects of different processing methods on quality of dried ginger from Qianwei[J]. Lishizhen Med Mater Med Res, 2007, 18(10): 2416-2418. https://www.cnki.com.cn/Article/CJFDTOTAL-SZGY200710047.htm
|
[11] |
JOLAD SD, LANTZ RC, CHEN GJ, et al. Commercially processed dry ginger (Zingiber officinale): Composition and effects on LPS-stimulated PGE2 production[J]. Phytochemistry, 2005, 66(13): 1614-1635. doi: 10.1016/j.phytochem.2005.05.007
|
[12] |
唐慎微. 大观本草[M]. 合肥: 安徽科学技术出版社, 2002: 255-256.
TANG SW. Daguan Materia Medica[M]. Hefei: Anhui science & technology publishing house, 2002: 255-256.
|
[13] |
DOUI M, MIKAGE M. The relationship between the color value and pungent compound contents of ginger subjected to heating, soaking in hot water, or steaming[J]. J Tradit Med, 2012, 29(3): 115-123.
|
[14] |
TSUKASA F, RIHITO Y, KOICHIRO T, et al. Decoction time and amount of aconitine-type diethyl alkaloid contained in the decoction of the unrefined aconite combination formula of Song version of "Treatise on Cold Damage"[J]. JPN Med J, 2019, 70(4): 313-323.
|
[15] |
MISATO D, MASAYUKI M. Historical study on the therapeutic method of ginger and dry ginger[J]. Nippon Med J, 2012, 63(4): 266-274.
|
[16] |
LIU Y, LIU J, ZHANG Y. Zingiber officinale research progress on chemical constituents of roscoe[J]. BioMed Res Int, 2019, 2019: 5370823.
|
[17] |
KIYAMA R. Nutritional implications of ginger: Chemistry, biological activities and signaling pathways[J]. J Nutr Biochem, 2020, 86: 108486. doi: 10.1016/j.jnutbio.2020.108486
|
[18] |
LI X, AO MY, ZHANG CL, et al. Zingiberis rhizoma recens: A review of its traditional uses, phytochemistry, pharmacology, and toxicology[J]. Evid Based Complement Alternat Med, 2021, 2021: 6668990.
|
[19] |
HORI Y, WAKABAYASHI Y, MIZUI K, et al. Pharmacognostic Studies on Ginger and Related Drugs (part 2): Constituents of Zingiberis Processum Rhizome (Kankyo)[J]. J Pharm Sci Showa Univ, 2012, 3(1): 67-76.
|
[20] |
YASUE K, JUNKO U, NOBUJI N. Constitutents of Zingiberaceae. Ⅰ. Diarylheptanoids from the Rhizomes of Ginger (Zingiber officinale ROSCOE)[J]. Chemical Pharm Bull, 1991, 39(1): 120-122. doi: 10.1248/cpb.39.120
|
[21] |
孙凤娇, 李振麟, 钱士辉, 等. 干姜化学成分和药理作用研究进展[J]. 中国野生植物资源, 2015, 34(3): 34-37. https://www.cnki.com.cn/Article/CJFDTOTAL-ZYSZ201503010.htm
SUN FJ, LI ZL, QIAN SH, et al. Research advances on the zingiberis rhizoma[J]. Chin Wild Plant Resour, 2015, 34(3): 34-37. https://www.cnki.com.cn/Article/CJFDTOTAL-ZYSZ201503010.htm
|
[22] |
张国裕, 李淑贤. 中药干姜挥发油化学成分的GC-MS分析[J]. 黑龙江医药科学, 2021, 44(4): 19-20. https://www.cnki.com.cn/Article/CJFDTOTAL-KXJY202104011.htm
ZHANG GY, LI SX. GC-MS analysis of the chemical constituents of the volatile oil from dried ginger[J]. Heilongjiang Med Pharm, 2021, 44(4): 19-20. https://www.cnki.com.cn/Article/CJFDTOTAL-KXJY202104011.htm
|
[23] |
Pharmaceuticals and Medical Devices Agency of Japan. The Japanese Pharmacopoeia[S]. 18th ed. Tokyo: the Ministry of Health, Labor and Welfare, 2021: 2109-2110.
|
[24] |
U.S. Pharmacopeial Convention. USP 36-NF31[S]. 36th revision, 31th ed. Rockville: The United States Pharmacopeial Convention, 2012: 1470-1472.
|
[25] |
罗京超, 冯毅凡, 吉星. 天然线性二苯基庚烷类化合物的研究进展[J]. 中草药, 2008, 39(12): 1912-1917. https://www.cnki.com.cn/Article/CJFDTOTAL-ZCYO200812056.htm
LUO JC, FENG YF, JI X. Advances in study on prooxidation and cytotoxicity of flavonoids[J]. Chin Tradit Herb Drugs, 2008, 39(12): 1912-1917. https://www.cnki.com.cn/Article/CJFDTOTAL-ZCYO200812056.htm
|
[26] |
BISCHOFF-KONT I, PRIMKE T, NIEBERGALL LS, et al. Ginger constituent 6-shogaol inhibits inflammation-and angiogenesis-related cell functions in primary human endothelial cells[J]. Front Pharmacol, 2022, 13: 844767. doi: 10.3389/fphar.2022.844767
|
[27] |
SANG SM, HONG J, WU H, et al. Increased growth inhibitory effects on human cancer cells and anti-inflammatory potency of shogaols from Zingiber officinale relative to gingerols[J]. J Agric Food Chem, 2009, 57(22): 10645-10650. doi: 10.1021/jf9027443
|
[28] |
KOU XR, WANG XQ, JI RY, et al. Occurrence, biological activity and metabolism of 6-shogaol[J]. Food Funct, 2018, 9(3): 1310-1327. doi: 10.1039/C7FO01354J
|
[29] |
IKUKO K, YUHEI H, SHUICHI Y. Inhibition of Peptide Leukotrienes (LTC4, LTD4, LTE 4) and LTB4 production by Saibokuto and its constituent herbal medicines[J]. Allergy, 1996, 45(6): 577-583.
|
[30] |
KISHORE N, KUMAR P, SHANKER K, et al. Human disorders associated with inflammation and the evolving role of natural products to overcome[J]. Eur J Med Chem, 2019, 179: 272-309. doi: 10.1016/j.ejmech.2019.06.034
|
[31] |
BISCHOFF-KONT I, FURST R. Benefits of ginger and its constituent 6-shogaol in inhibiting inflammatory processes[J]. Pharmaceuticals, 2021, 14(6): 571. doi: 10.3390/ph14060571
|
[32] |
MAMI Y, SAORI H. Changes in 6-gingerol in ginger due to cooking[J]. J JPN Soc Culin Sci, 2015, 48(6): 398-404.
|
[33] |
MONTUSCHI P. Leukotrienes, antileukotrienes and asthma[J]. Mini Rev Med Chem, 2008, 8(7): 647-656. doi: 10.2174/138955708784567395
|
[34] |
YOCUM GT, HWANG JJ, MIKAMI M, et al. Ginger and its bioactive component 6-shogaol mitigate lung inflammation in a murine asthma model[J]. Am J Physiol Lung Cell Mol Physiol, 2020, 318(2): 296-303. doi: 10.1152/ajplung.00249.2019
|
[35] |
ARA T, KOIDE M, KITAMURA H, et al. Effects of shokyo (Zingiberis Rhizoma) and kankyo (Zingiberis Processum Rhizoma) on prostaglandin E2 production in lipopolysaccharide-treated mouse macrophage RAW264.7 cells[J]. Peer J, 2019, 7: e7725. doi: 10.7717/peerj.7725
|
[36] |
ARA T, NAKATANI S, KOBATA K, et al. The biological efficacy of natural products against acute and chronic inflammatory diseases in the oral region[J]. Medicines, 2018, 5(4): 122. doi: 10.3390/medicines5040122
|
[37] |
SAPKOTA A, PARK SJ, CHOI JW. Neuroprotective effects of 6-shogaol and its metabolite, 6-paradol, in a mouse model of multiple sclerosis[J]. Biomol Ther, 2019, 27(2): 152-159. doi: 10.4062/biomolther.2018.089
|
[38] |
ZHOU L, QI LW, JIANG LF, et al. Antitumor activity of gemcitabine can be potentiated in pancreatic cancer through modulation of TLR4/NF-κB signaling by 6-shogaol[J]. AAPS J, 2014, 16(2): 246-257. doi: 10.1208/s12248-013-9558-3
|
[39] |
RAY A, VASUDEVAN S, SENGUPTA S. 6-shogaol inhibits breast cancer cells and stem cell-like spheroids by modulation of Notch signaling pathway and induction of autophagic cell death[J]. PLoS ONE, 2015, 10(9): e0137614. doi: 10.1371/journal.pone.0137614
|
[40] |
CHEN HD, FU JS, CHEN H, et al. Ginger compound[6]-shogaol and its cysteine-conjugated metabolite (M2) activate Nrf2 in colon epithelial cells in vitro and in vivo[J]. Chem Res Toxicol, 2014, 27(9): 1575-1585. doi: 10.1021/tx500211x
|
[41] |
LIU Q, PENG YB, QI LW, et al. The cytotoxicity mechanism of 6-shogaol-treated HeLa human cervical cancer cells revealed by label-free shotgun proteomics and bioinformatics analysis[J]. Evid Based Complement Alternat Med, 2012, 2012: 278652.
|
[42] |
QI LW, ZHANG ZY, ZHANG CF, et al. Anti-colon cancer effects of 6-shogaol through G2/M cell cycle arrest by p53/p21-cdc2/cdc25A crosstalk[J]. Am J Chin Med, 2015, 43(4): 743-756. doi: 10.1142/S0192415X15500469
|
[43] |
HUANG H, KIM MO, KIM KR. Anticancer effects of 6-shogaol via the AKT signaling pathway in oral squamous cell carcinoma[J]. J Appl Oral Sci, 2021, 29: e20210209. doi: 10.1590/1678-7757-2021-0209
|
[44] |
JANG JY, MIN JH, CHAE YH, et al. Reactive oxygen species play a critical role in collagen-induced platelet activation via SHP-2 oxidation[J]. Antioxid Redox Signal, 2014, 20(16): 2528-2540. doi: 10.1089/ars.2013.5337
|
[45] |
YOUNG HY, LUO YL, CHENG HY, et al. Analgesic and anti-inflammatory activities of[6]-gingerol[J]. J Ethnopharmacol, 2005, 96(1/2): 207-210.
|
[46] |
王宇锋, 陈超, 杨银学, 等. 6-姜烯酚对H2O2诱导NCM460和HCT116氧化损伤的作用研究[J]. 现代食品科技, 2017, 33(12): 6-15. https://www.cnki.com.cn/Article/CJFDTOTAL-GZSP201712002.htm
WANG YF, CHEN C, YANG YX, et al. Effects of 6-shogaol on H2O2-induced oxidative damage in NCM460 and HCT116[J]. Mod Food Sci Technol, 2017, 33(12): 6-15. https://www.cnki.com.cn/Article/CJFDTOTAL-GZSP201712002.htm
|
[47] |
黄敏, 程珂, 马春松, 等. 6-姜烯酚对斑马鱼肝脏细胞炎症通路和抗氧化作用的影响[J]. 华中农业大学学报, 2022, 41(1): 202-209. https://www.cnki.com.cn/Article/CJFDTOTAL-HZNY202201020.htm
HUANG M, CHENG K, MA CS, et al. Effects of 6-shogaol on inflammation response and antioxidant capacity in zebrafish liver cells[J]. J Huazhong Agric Univ, 2022, 41(1): 202-209. https://www.cnki.com.cn/Article/CJFDTOTAL-HZNY202201020.htm
|
[48] |
NONAKA K, BANDO M, SAKAMOTO E, et al. 6-shogaol inhibits advanced glycation end-products-induced IL-6 and ICAM-1 expression by regulating oxidative responses in human gingival fibroblasts[J]. Molecules, 2019, 24(20): 3705. doi: 10.3390/molecules24203705
|
[49] |
LIU J, LI B, LI WL, et al. 6-shogaol inhibits oxidative stress-induced rat vascular smooth muscle cell apoptosis by regulating OXR1-p53 axis[J]. Front Mol Biosci, 2022, 9: 808162. doi: 10.3389/fmolb.2022.808162
|
[50] |
许庆文, 卢传坚, 欧明, 等. 干姜提取物对兔急性心衰模型的保护和治疗作用[J]. 中药新药与临床药理, 2004, 15(4): 244-247. https://www.cnki.com.cn/Article/CJFDTOTAL-ZYXY200404006.htm
XU QW, LU CJ, OU M, et al. Preventive and thearapeutic effects of ginger extraction on rabbits with acute heart failure[J]. Tradit Chin Drug Res Clin Pharmacol, 2004, 15(4): 244-247. https://www.cnki.com.cn/Article/CJFDTOTAL-ZYXY200404006.htm
|
[51] |
廖晖, 王慧梅, 王春莲, 等. 干姜擦剂治疗手足皲裂70例[J]. 中国中西医结合杂志, 2001, 21(6): 469. https://www.cnki.com.cn/Article/CJFDTOTAL-ZZXJ200106042.htm
LIAO H, WANG HM, WANG CL, et al. 70 cases of chapped hands and feet treated with dried ginger liniment[J]. Chin J Integr Tradit West Med, 2001, 21(6): 469. https://www.cnki.com.cn/Article/CJFDTOTAL-ZZXJ200106042.htm
|
[52] |
柳俊辉, 秦华珍, 刘颖, 等. 基于胃实寒证的10味温中散寒药温热药性与温通作用研究[J]. 中药新药与临床药理, 2014, 25(4): 414-418. https://www.cnki.com.cn/Article/CJFDTOTAL-ZYXY201404008.htm
LIU JH, QIN HZ, LIU Y, et al. Correlation of warm-heat nature of ten herbs with their effects of warming middle-Jiao and dispelling cold on rats with stomach excess-cold syndrome[J]. Tradit Chin Drug Res Clin Pharmacol, 2014, 25(4): 414-418. https://www.cnki.com.cn/Article/CJFDTOTAL-ZYXY201404008.htm
|
[53] |
蒋苏贞, 廖康. 干姜醇提取物对实验性胃溃疡的影响[J]. 中国民族民间医药, 2010, 19(8): 79-80. https://www.cnki.com.cn/Article/CJFDTOTAL-MZMJ201008064.htm
JIANG SZ, LIAO K. Effect of alcohol extract of dried ginger on experimental gastric ulcer[J]. Chin J Ethnomed Ethnopharmacy, 2010, 19(8): 79-80. https://www.cnki.com.cn/Article/CJFDTOTAL-MZMJ201008064.htm
|
[54] |
张广龙, 毕娉娉, 李雅琦, 等. 6-姜酚对化疗性大鼠胃动力障碍的影响及作用机制研究[J]. 中药药理与临床, 2021, 37(1): 84-88. https://www.cnki.com.cn/Article/CJFDTOTAL-ZYYL202101015.htm
ZHANG GL, BI PP, LI YQ, et al. Effects of 6-gingerol on chemotherapy-induced gastric motility disorder in rats[J]. Pharmacol Clin Chin Mater Med, 2021, 37(1): 84-88. https://www.cnki.com.cn/Article/CJFDTOTAL-ZYYL202101015.htm
|
[55] |
BRAHMA NAIDU P, UDDANDRAO VV, RAVINDAR NAIK R, et al. Ameliorative potential of gingerol: Promising modulation of inflammatory factors and lipid marker enzymes expressions in HFD induced obesity in rats[J]. Mol Cell Endocrinol, 2016, 419: 139-147.
|
[56] |
CHOI J, KIM KJ, KIM BH, et al. 6-Gingerol suppresses adipocyte-derived mediators of inflammation in vitro and in high-fat diet-induced obese Zebra fish[J]. Planta Med, 2017, 83(3/4): 245-253.
|
[57] |
付加雷. 姜油酮的现代药理作用研究进展[J]. 环球中医药, 2022, 15(9): 1736-1741. https://www.cnki.com.cn/Article/CJFDTOTAL-HQZY202209047.htm
FU JL. Review on modern pharmacological properties of zingerone[J]. Glob Tradit Chin Med, 2022, 15(9): 1736-1741. https://www.cnki.com.cn/Article/CJFDTOTAL-HQZY202209047.htm
|
[58] |
BERA K, NOSALOVA G, SIVOVA V, et al. Structural elements and cough suppressing activity of polysaccharides from Zingiber officinale rhizome[J]. Phytother Res, 2016, 30(1): 105-111.
|
[59] |
PALATTY PL, HANIADKA R, VALDER B, et al. Ginger in the prevention of nausea and vomiting: A review[J]. Crit Rev Food Sci Nutr, 2013, 53(7): 659-669.
|
[60] |
WALSTAB J, KRüGER D, STARK T, et al. Ginger and its pungent constituents non-competitively inhibit activation of human recombinant and native 5-HT3 receptors of enteric neurons[J]. Neurogastroenterol Motil, 2013, 25(5): 439-447, e302.
|
[61] |
KONMUN J, DANWILAI K, NGAMPHAIBOON N, et al. A phase Ⅱ randomized double-blind placebo-controlled study of 6-gingerol as an anti-emetic in solid tumor patients receiving moderately to highly emetogenic chemotherapy[J]. Med Oncol, 2017, 34(4): 69.
|
[62] |
刘昌孝. 从中药资源-质量-质量标志物认识中药产业的健康发展[J]. 中草药, 2016, 47(18): 3149-3154. https://www.cnki.com.cn/Article/CJFDTOTAL-ZCYO201618003.htm
LIU CX. Recognizing healthy development of Chinese medicine industry from resourcesquality-quality markers of Chinese medicine[J]. Chin Tradit Herb Drugs, 2016, 47(18): 3149-3154. https://www.cnki.com.cn/Article/CJFDTOTAL-ZCYO201618003.htm
|
[63] |
吴德邻. 姜科植物地理[J]. 热带亚热带植物学报, 1994, 2(2): 1-14. https://www.cnki.com.cn/Article/CJFDTOTAL-RYZB402.000.htm
WU TL. Phytogeography of the Zingiberaceae[J]. J Trop Subtrop Bot, 1994, 2(2): 1-14. https://www.cnki.com.cn/Article/CJFDTOTAL-RYZB402.000.htm
|
[64] |
龙小琴, 秦华珍, 黄燕琼, 等. 姜科五属中药性效与亲缘关系相关性研究进展[J]. 中国药房, 2016, 27(23): 3301-3304. https://www.cnki.com.cn/Article/CJFDTOTAL-ZGYA201623051.htm
LONG XQ, QIN HZ, HUANG YQ, et al. Research progress on the correlation between sexual efficacy and genetic relationship of five Genera of Chinese medicine in Zingiberaceae[J]. China Pharm, 2016, 27(23): 3301-3304. https://www.cnki.com.cn/Article/CJFDTOTAL-ZGYA201623051.htm
|